Results 161 to 170 of about 22,351 (243)

Neuroprotective crosstalk from vitamin B12 and sphingolipid signaling pathways in therapy for multiple sclerosis. [PDF]

Int Immunol
Kihara Y, Chun J.
europepmc   +1 more source

Visceral leishmaniasis in a multiple sclerosis patient: a rare complication of fingolimod-induced lymphopenia. [PDF]

Rev Esp Quimioter
García-Alabarce A, Cornejo-Calvo E, de Salazar-González A, Guirao-Arrabal E.   +3 more
europepmc   +1 more source

Repeatedly occurring retrograde menstruation intensifies central sensitization driven by neuroinflammation in endometriosis models. [PDF]

J Clin Invest
Harvey ME, Shi M, Oh Y, Page TM, Mitchell DA, Luo A, Slayden OD, MacLean JA, Sharma A, Hayashi K.   +9 more
europepmc   +1 more source

Three cases of non-carryover fingolimod-PML

, 2019
\(\bf Objective\) To report the course of 3 recent Japanese and European cases of fingolimod-associated progressive multifocal leukoencephalopathy (PML) and to analyze its risk factors and increased incidence in Japan.
Nakahara, Jin (PhD), Kamada, Masaki (PhD), Ayzenberg, Ilya (Prof. Dr. med.), Kufukihara, Kenji (MD), Takata, Tadayuki (MD), Tomaske, Laura, Schneider, Ruth (Dr. med.), Kume, Kodai (PhD), Deguchi, Kazushi (PhD), Gold, Ralf (Prof. Dr. med.)   +9 more
core  

Pilot Study of Fingolimod Treatment in Neuronal Ceroid Lipofuscinosis Type 1. [PDF]

Neurol Genet
Messina M, Whiteley R, Gan C, Heywood WE, Heslegrave AJ, Keating M, Taylor S, Footitt E, Mills P, Hemingway C, Gissen P, Vecchiato K.   +11 more
europepmc   +1 more source

Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis: A Real-World Study from Jordan. [PDF]

Medicina (Kaunas)
Al Anber A, Abu Al Karsaneh O, Abuquteish D, Abdallah O, Issa MA, Sa'adeh M, Kilani D.   +6 more
europepmc   +1 more source

Oral HPV-Related Epithelial Proliferation during Fingolimod Therapy: First Case Report and Review of the Literature. [PDF]

Head Neck Pathol
Tikkhanarak K, Saepoo J, Handoo N, Lanzel E, Timmons S, Frost R, Hellstein J.   +6 more
europepmc   +1 more source

Fingolimod Effects on Motor Function and BDNF-TrkB Signaling in a Huntington's Mouse Model Are Disease-Stage-Dependent. [PDF]

Int J Mol Sci
Nguyen KQ, Rymar VV, Sadikot AF.
europepmc   +1 more source

Clinical and radiological outcomes of directed treatment transitions from Gilenya^® to generic fingolimod. [PDF]

Mult Scler
Patel MA, Punnen TG, Shan KS, McCreary MC, Wright CM, Munoz SB, Hardeman P, Burgess KW, Greenberg BM, Horton LA, Sguigna PV, Tardo LM, Stüve O, Okuda DT.   +13 more
europepmc   +1 more source

Treatment Effects on Chronic Active Lesions in Multiple Sclerosis: Current Evidence and Future Perspectives. [PDF]

Neurol Ther
Preziosa P, Guido G, Filippi M, Rocca MA.   +3 more
europepmc   +1 more source